Oruka Therapeutics, Inc. (ORKA) Total liabilities 2016–2023
Oruka Therapeutics, Inc. (ORKA) total liabilities at each fiscal year-end, per SEC filings.
$841,000FY2023 · since FY2016: $2.4M → $841,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $841,000 | -40.4% |
| FY2022 | $1.4M | -63.6% |
| FY2021 | $3.9M | -0.7% |
| FY2020 | $3.9M | +322.0% |
| FY2019 | $926,000 | +16.8% |
| FY2018 | $793,000 | -62.1% |
| FY2017 | $2.1M | -14.2% |
| FY2016 | $2.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More ORKA financial trends
ORKA RevenueORKA Net incomeORKA Net marginORKA Gross profitORKA Gross marginORKA Operating incomeORKA Operating marginORKA Operating cash flowORKA Free cash flowORKA Capital expendituresORKA Return on equityORKA Stock buybacksORKA Dividends paidORKA Total assetsORKA Shareholders’ equityORKA overview →